Login / Signup

Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.

Shristhi RanjithHesitha AbeysunderaHilary Jeyaranjan
Published in: BMJ case reports (2023)
There is limited information about sodium valproate-induced hyperammonaemia encephalopathy (VPAIHE). The aim of this case report is to provide medical practitioners with a greater awareness of the possible development of hyperammonaemia due to sodium valproate use and its associated complications.This paper describes a middle-aged man with a history of bipolar affective disorder who was admitted with a manic relapse secondary to medication non-compliance. His admission was complicated by an intensive care unit admission to manage medical compromise in the context of sodium VPAIHE.
Keyphrases
  • intensive care unit
  • bipolar disorder
  • healthcare
  • case report
  • middle aged
  • high glucose
  • diabetic rats
  • early onset
  • drug induced
  • oxidative stress
  • endothelial cells
  • risk factors
  • adverse drug
  • social media
  • general practice